Bottom line
RLSDX vs VCSH: the short answer
RLSDX (Lazard US Short Duration Fixed Income Portfolio) and VCSH (Vanguard Short-Term Corporate Bond Index Fund) are both mutual funds.
VCSH is cheaper at 0.03% vs 0.35% — a difference of $32 a year per $10,000 invested.
Over five years, RLSDX returned +2.0% a year vs +1.9% for VCSH (reporting dates differ).
Updated Nov 19, 2026
RLSDX vs VCSH side by side
| RLSDX | VCSH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Lazard | Vanguard |
| Category | Short-Term Bond | Short-Term Bond |
| Expense ratio | 0.35% | 0.03% |
| Annual cost per $10k | $35 | $3 |
| 10-yr cost on $10k (prospectus) | $871 | $39 |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +4.7% | +5.0% |
| 5-yr return (annualized) | +2.0% | +1.9% |
| 10-yr return (annualized) | +1.8% | +2.4% |
| Best quarter | — | +5.6% |
| Worst quarter | — | −3.7% |
| Net assets (fund) | — | $50.2B |
| Number of holdings | — | 3,004 |
| Portfolio turnover | 164% | 73% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
RLSDX and VCSH share none of their top holdings.
RLSDX top 10
VCSH top 10
- United States Treasury Note/Bond — 0.83%
- Vanguard Cmt Funds-Vanguard Market Liquidity Fund — 0.55%
- Bank of America Corp — 0.23%
- AbbVie Inc — 0.21%
- CVS Health Corp — 0.20%
- T-Mobile USA Inc — 0.19%
- Boeing Co/The — 0.19%
- Wells Fargo & Co — 0.18%
- JPMorgan Chase & Co — 0.18%
- Pfizer Investment Enterprises Pte Ltd — 0.17%
FAQ
What is the difference between RLSDX and VCSH?
RLSDX (Lazard US Short Duration Fixed Income Portfolio) and VCSH (Vanguard Short-Term Corporate Bond Index Fund) are both mutual funds. VCSH is cheaper at 0.03% vs 0.35% — a difference of $32 a year per $10,000 invested.
Which is cheaper, RLSDX or VCSH?
VCSH has the lower expense ratio (0.03%).
Should I own both RLSDX and VCSH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.